MedTrace Logo

Quantitative Refractive Crosslinking in Presbyopia Aged Patients

NCT07137767 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-08-29

No results posted yet for this study

Summary

An 'on-eye' UV delivery system for corneal crosslinking can be used safely and effectively to help free presbyopic patients from the need for reading glasses.

Conditions

Interventions

DEVICE

Quantitative refractive crosslinking

Non-invasive corneal crosslinking device delivering controlled UV light through a contact lens platform for refractive reshaping of the cornea.

Sponsors & Collaborators

  • Renato Ambrósio, MD - Rio Vision; Tijuca Rio de Janeiro, Brazil

    collaborator UNKNOWN

  • Juan Batlle, Jr. MD - Laser Center; Santo Domingo, Dominican Rep.

    collaborator UNKNOWN

  • TECLens, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • Brazil
  • Dominican Republic

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07137767 on ClinicalTrials.gov